Approach to Elevated Liver Enzymes in IBD

This IBD clinical care pathway is a tool providing healthcare providers direction on the evaluation of elevated liver enzymes in patients with inflammatory bowel disease.
 

Download the PDF


Disclaimer: Clinical care pathways are not a substitute for the personalized judgement and care of a trained healthcare professional.

Dr. Aldo J. Montano-Loza (University of Alberta) and Dr. Alex Frolkis (University of Calgary) led the review and update for the current version of this clinical care pathway.

Additional resources  

For people with IBD  



For IBD providers 

 

Please provide us with feedback! 

If you have used this clinical care pathway, please take a moment to fill out this survey to provide your valuable feedback!

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest

Gutsy Walk Tote
Go Here
Volunteer